Sounds like Avigan (favipiravir) trial is done as expected. I'd like to see the final data first, but this will be a good addition. It's cheap ($100~150/person) & should be widely available, as it's already made in Japan & China (& India & Russia, as I understand).
https://twitter.com/NikkeiAsia/status/1307763986029568004
It's oral & much much cheaper than remdesivir (IV, $2~3k) & much cheaper.
Major downside is its teratogenicity (causes birth defects), but that shouldn't be an issue for the seniors that are hit the hardest by Covid.
Major downside is its teratogenicity (causes birth defects), but that shouldn't be an issue for the seniors that are hit the hardest by Covid.
Fujifilm vs. Kodak continues.
cc:@NickytaLeb
Fujifilm to apply for approval next month, approval possible by the end of year.
(it is already approved for use w/ stricter conditions, so no big rush in reality).
nikkei.com/article/DGXMZO…
(it is already approved for use w/ stricter conditions, so no big rush in reality).
nikkei.com/article/DGXMZO…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
